abs420.txt	a	strong	positive	association	has	been	observed	between	circulatinganti-m√ºllerian	hormone	(amh)		biomarker	of	ovarian	reserve	and	breast	cancerrisk	in	three	prospective	studies	confirming	this	is	importantbecause	the	paucity	biomarkers	cancer	risk	premenopausalwomen	we	conducted	consortium	study	including	ten	cohorts	that	hadcollected	blood	from	premenopausal	women	nested	case-control	design	wasimplemented	within	each	cohort	total	2	835	invasive	(80%)	situ	(20%)breast	cases	were	individually	matched	to	controls	(n	=	3	122)	on	age	atblood	donation	amh	was	measured	using	high	sensitivity	enzyme-linkedimmunoabsorbent	assay	conditional	logistic	regression	applied	theaggregated	dataset	there	statistically	significant	trend	increasingbreast	with	increasing	concentration	(ptrend	across	quartiles<0	0001)	after	adjusting	for	factors	odds	ratio	(or)	forbreast	top	vs	bottom	quartile	1	60	(95%ci	31-1	94)	though	test	interaction	not	statisticallysignificant	(pinteraction	0	15)	onlyfor	tumors	both	estrogen	receptor	(er)	progesterone	receptor(pr)	er+/pr+	orq4-q1	96	95%	ci	46-2	64	ptrend	<0	0001	er+/pr-	82	40-1	68	51	er-/pr+	23	48-21	9	26	er-/pr-	15	63-2	09	pre-	(orq4-q1	35	95%ci	05-1	73)	post-menopausal	61	03-2	53)	breastcancer	34)	large	confirmed	thatamh	associated	60%	increase	womenin
